BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND ACVR1, SKR1, 90, ENSG00000115170, Q04771, ACVRLK2, FOP, ALK2, ACTRI
4203 results:

  • 1. Racial and Ethnic Inequities in cancer Care Continuity During the COVID-19 Pandemic Among Those With SARS-CoV-2.
    Islam JY; Hathaway CA; Hume E; Turner K; Hallanger-Johnson J; Tworoger SS; Camacho-Rivera M
    JAMA Netw Open; 2024 May; 7(5):e2412050. PubMed ID: 38767916
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Enhanced anti-tumor efficacy with multi-transgene armed mesenchymal stem cells for treating peritoneal carcinomatosis.
    Ho YK; Woo JY; Loke KM; Deng LW; Too HP
    J Transl Med; 2024 May; 22(1):463. PubMed ID: 38750559
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Transcript and protein signatures derived from shared molecular interactions across cancers are associated with mortality.
    Zhao Y; Li X; Loscalzo J; Smelik M; Sysoev O; Wang Y; Mahmud AKMF; Mansour Aly D; Benson M
    J Transl Med; 2024 May; 22(1):444. PubMed ID: 38734658
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Diagnosing and staging epithelial ovarian cancer by serum glycoproteomic profiling.
    Dhar C; Ramachandran P; Xu G; Pickering C; Čaval T; Wong M; Rice R; Zhou B; Srinivasan A; Aiyetan P; Chu CW; Moser K; Herzog TJ; Olawaiye AB; Jacob F; Serie D; Lindpaintner K; Schwarz F
    Br J Cancer; 2024 Jun; 130(10):1716-1724. PubMed ID: 38658783
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or ovarian cancer.
    Torres-Esquius S; Llop-Guevara A; Gutiérrez-Enríquez S; Romey M; Teulé À; Llort G; Herrero A; Sánchez-Henarejos P; Vallmajó A; González-Santiago S; Chirivella I; Cano JM; Graña B; Simonetti S; Díaz de Corcuera I; Ramon Y Cajal T; Sanz J; Serrano S; Otero A; Churruca C; Sánchez-Heras AB; Servitja S; Guillén-Ponce C; Brunet J; Denkert C; Serra V; Balmaña J
    JAMA Netw Open; 2024 Apr; 7(4):e247811. PubMed ID: 38648056
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Randomized Phase II Study of Gemcitabine With or Without ATR Inhibitor Berzosertib in Platinum-Resistant ovarian cancer: Final Overall Survival and Biomarker Analyses.
    Konstantinopoulos PA; Cheng SC; Lee EK; da Costa AABA; Gulhan D; Wahner Hendrickson AE; Kochupurakkal B; Kolin DL; Kohn EC; Liu JF; Penson RT; Stover EH; Curtis J; Sawyer H; Polak M; Chowdhury D; D'Andrea AD; Färkkilä A; Shapiro GI; Matulonis UA
    JCO Precis Oncol; 2024 Apr; 8():e2300635. PubMed ID: 38635934
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Customizable Porphyrin Platform Enables Folate Receptor PET Imaging Using Copper-64.
    Houson HA; Wu Z; Cao PD; Lindsey JS; Lapi SE
    Mol Pharm; 2024 May; 21(5):2441-2455. PubMed ID: 38623055
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Ultrasound-based deep learning radiomics model for differentiating benign, borderline, and malignant ovarian tumours: a multi-class classification exploratory study.
    Du Y; Guo W; Xiao Y; Chen H; Yao J; Wu J
    BMC Med Imaging; 2024 Apr; 24(1):89. PubMed ID: 38622546
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Gonadoblastoma: Clinicopathological study and literature review of 3 cases].
    Bao ML; Li X; Chen G; Li H; Chen W; Li HX
    Zhonghua Nan Ke Xue; 2023 Jul; 29(7):634-638. PubMed ID: 38619412
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Functional analysis and validation of oncodrive gene AP3S1 in ovarian cancer through filtering of mutation data from whole-exome sequencing.
    Kong D; Wu Y; Liu Q; Huang C; Wang T; Huang Z; Gao Y; Li Y; Guo H
    Eur J Med Res; 2024 Apr; 29(1):231. PubMed ID: 38609993
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Bayesian and deep-learning models applied to the early detection of ovarian cancer using multiple longitudinal biomarkers.
    Abrego L; Zaikin A; Marino IP; Krivonosov MI; Jacobs I; Menon U; Gentry-Maharaj A; Blyuss O
    Cancer Med; 2024 Apr; 13(7):e7163. PubMed ID: 38597129
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Tumor-Infiltrating Lymphocytes in Triple-Negative Breast cancer.
    Leon-Ferre RA; Jonas SF; Salgado R; Loi S; de Jong V; Carter JM; Nielsen TO; Leung S; Riaz N; Chia S; Jules-Clément G; Curigliano G; Criscitiello C; Cockenpot V; Lambertini M; Suman VJ; Linderholm B; Martens JWM; van Deurzen CHM; Timmermans AM; Shimoi T; Yazaki S; Yoshida M; Kim SB; Lee HJ; Dieci MV; Bataillon G; Vincent-Salomon A; André F; Kok M; Linn SC; Goetz MP; Michiels S;
    JAMA; 2024 Apr; 331(13):1135-1144. PubMed ID: 38563834
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Subsequent management and outcomes after first-line PARP inhibitors progression in ovarian cancer patients.
    Yuan H; Li N; Wu L; Yao H
    J Ovarian Res; 2024 Apr; 17(1):70. PubMed ID: 38561819
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Comparison of the multiples of the median of serum anti-müllerian hormone and pregnancy outcomes in patients with gestational trophoblastic disease: A case-control study.
    Lai THT; Lau LSK; Ngu SF; Chu MYM; Chan KKL; Ng EHY; Ngan HYS; Li RHW; Tse KY
    Cancer Med; 2024 Apr; 13(7):e7134. PubMed ID: 38545760
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The impact of varying levels of residual disease following cytoreductive surgery on survival outcomes in patients with ovarian cancer: a meta-analysis.
    Chase DM; Mahajan A; Scott DA; Hawkins N; Kalilani L
    BMC Womens Health; 2024 Mar; 24(1):179. PubMed ID: 38491366
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Survival of European adolescents and young adults diagnosed with cancer in 2010-2014.
    Trama A; Botta L; Stiller C; Visser O; Cañete-Nieto A; Spycher B; Bielska-Lasota M; Katalinic A; Vener C; Innos K; Marcos-Gragera R; Paapsi K; Guevara M; Demuru E; Mousavi SM; Blum M; Eberle A; Ferrari A; Bernasconi A; Lasalvia P;
    Eur J Cancer; 2024 May; 202():113558. PubMed ID: 38489859
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. ovarian Suppression: Early Menopause and Late Effects.
    Molinelli C; Jacobs F; Nader-Marta G; Borea R; Scavone G; Ottonello S; Fregatti P; Villarreal-Garza C; Bajpai J; Kim HJ; Puglisi S; de Azambuja E; Lambertini M
    Curr Treat Options Oncol; 2024 Apr; 25(4):523-542. PubMed ID: 38478329
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Adjuvant ovarian Function Suppression in Premenopausal Hormone Receptor-Positive Breast cancer.
    Basmadjian RB; Lupichuk S; Xu Y; Quan ML; Cheung WY; Brenner DR
    JAMA Netw Open; 2024 Mar; 7(3):e242082. PubMed ID: 38477918
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A clinicopathological study about the epidemiology of granulosa cell tumors in Lebanon.
    Yaacoub S; Hajj L; Khairallah A
    BMC Cancer; 2024 Mar; 24(1):309. PubMed ID: 38448917
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Fat intake modifies association between cigarette smoking and lung cancer in a prospective cohort study: A potential explanation for the lung cancer paradox.
    Reger M; Hoyt M; Nan H; Fan H; Zhang J
    Clin Nutr; 2024 Apr; 43(4):960-968. PubMed ID: 38447490
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 211.